Weekly shot tested to control HIV in new patients
NCT ID NCT06061536
Summary
This study tested a new weekly injection called Lipovirtide, given alongside standard daily pills, to control HIV in people who had never been treated before. It involved 64 participants and aimed to find the most effective and safe dose. The main goal was to see how well the combination could reduce the amount of virus in the blood over about six months.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Tianjin Second People's Hospital
Tianjin, Tianjin Municipality, 300000, China
Conditions
Explore the condition pages connected to this study.